Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study.
Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care Hospital in Oman.
Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: Results from the Ausimmune Study.
Progressive MS: from pathophysiology to drug discovery.
Gene set differential analysis of time course expression profiles via sparse estimation in functional logistic model with application to time-dependent biomarker detection.
AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
Neuromyelitis optica in a Ugandan woman: a case report.
Genetic factors and multiple sclerosis in the Moroccan population: A role for HLA class II.
[(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy.
Errata-corrige. Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis.
The effect of whole-body, repetitive, inhomogeneous static magnetic field-exposure on the symptoms of experimental autoimmune encephalomyelitis in mice.
Multiple sclerosis: Etiology, incidence and prevalence.
Immunopathology of multiple sclerosis.
Generating induced pluripotent stem cells for multiple sclerosis therapy.
Analysis of the treatment of neuromyelitis optica.
Neurodegenerative diseases in the era of targeted therapeutics: how to handle a tangled issue.
Longitudinal associations between brain structural changes and fatigue in early MS.
Is customized vestibular rehabilitation effective in patients with multiple sclerosis? A randomized controlled trial.
Intermittent alien hand syndrome and callosal apraxia in multiple sclerosis: implications for interhemispheric communication.
Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials.
Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models.
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.
Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy.
Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry.

Pages